Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,647 | -8,277 | -8,079 | -9,653 | -23,770 |
| Depreciation Amortization | 109 | 110 | 127 | 150 | 194 |
| Other Working Capital | -27 | 487 | -888 | -910 | -3,821 |
| Other Operating Activity | 414 | 679 | 505 | -1,371 | 6,970 |
| Operating Cash Flow | $-12,151 | $-7,001 | $-8,335 | $-11,784 | $-20,427 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17 | -35 | -8 | N/A | 3 |
| Investing Cash Flow | $-17 | $-35 | $-8 | $N/A | $3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 35,194 | 2,800 | 3,317 | 17,154 | 11,094 |
| Other Financing Activity | 0 | 6,295 | 0 | 0 | 0 |
| Financing Cash Flow | $35,194 | $9,095 | $3,317 | $17,154 | $11,094 |
| Beginning Cash Position | 7,005 | 4,946 | 9,972 | 4,602 | 13,932 |
| End Cash Position | 30,031 | 7,005 | 4,946 | 9,972 | 4,602 |
| Net Cash Flow | $23,026 | $2,059 | $-5,026 | $5,370 | $-9,330 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,151 | -7,001 | -8,335 | -11,784 | -20,427 |
| Capital Expenditure | -17 | -35 | -8 | N/A | 3 |
| Free Cash Flow | -12,168 | -7,036 | -8,343 | -11,784 | -20,424 |